These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

320 related items for PubMed ID: 9261383

  • 1. Epstein-Barr virus nuclear protein LP stimulates EBNA-2 acidic domain-mediated transcriptional activation.
    Harada S, Kieff E.
    J Virol; 1997 Sep; 71(9):6611-8. PubMed ID: 9261383
    [Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus leader protein enhances EBNA-2-mediated transactivation of latent membrane protein 1 expression: a role for the W1W2 repeat domain.
    Nitsche F, Bell A, Rickinson A.
    J Virol; 1997 Sep; 71(9):6619-28. PubMed ID: 9261384
    [Abstract] [Full Text] [Related]

  • 3. Protein kinase A associates with HA95 and affects transcriptional coactivation by Epstein-Barr virus nuclear proteins.
    Han I, Xue Y, Harada S, Orstavik S, Skalhegg B, Kieff E.
    Mol Cell Biol; 2002 Apr; 22(7):2136-46. PubMed ID: 11884601
    [Abstract] [Full Text] [Related]

  • 4. Residues 231 to 280 of the Epstein-Barr virus nuclear protein 2 are not essential for primary B-lymphocyte growth transformation.
    Harada S, Yalamanchili R, Kieff E.
    J Virol; 1998 Dec; 72(12):9948-54. PubMed ID: 9811732
    [Abstract] [Full Text] [Related]

  • 5. Epstein-barr virus nuclear antigen 3C activates the latent membrane protein 1 promoter in the presence of Epstein-Barr virus nuclear antigen 2 through sequences encompassing an spi-1/Spi-B binding site.
    Zhao B, Sample CE.
    J Virol; 2000 Jun; 74(11):5151-60. PubMed ID: 10799590
    [Abstract] [Full Text] [Related]

  • 6. Epstein-Barr virus nuclear antigen 3C putative repression domain mediates coactivation of the LMP1 promoter with EBNA-2.
    Lin J, Johannsen E, Robertson E, Kieff E.
    J Virol; 2002 Jan; 76(1):232-42. PubMed ID: 11739688
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus nuclear protein 3C modulates transcription through interaction with the sequence-specific DNA-binding protein J kappa.
    Robertson ES, Grossman S, Johannsen E, Miller C, Lin J, Tomkinson B, Kieff E.
    J Virol; 1995 May; 69(5):3108-16. PubMed ID: 7707539
    [Abstract] [Full Text] [Related]

  • 8. EBNA-2 upregulation of Epstein-Barr virus latency promoters and the cellular CD23 promoter utilizes a common targeting intermediate, CBF1.
    Ling PD, Hsieh JJ, Ruf IK, Rawlins DR, Hayward SD.
    J Virol; 1994 Sep; 68(9):5375-83. PubMed ID: 8057421
    [Abstract] [Full Text] [Related]

  • 9. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
    Sjöblom A, Nerstedt A, Jansson A, Rymo L.
    J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
    [Abstract] [Full Text] [Related]

  • 10. Conserved region CR2 of Epstein-Barr virus nuclear antigen leader protein is a multifunctional domain that mediates self-association as well as nuclear localization and nuclear matrix association.
    Tanaka M, Yokoyama A, Igarashi M, Matsuda G, Kato K, Kanamori M, Hirai K, Kawaguchi Y, Yamanashi Y.
    J Virol; 2002 Feb; 76(3):1025-32. PubMed ID: 11773378
    [Abstract] [Full Text] [Related]

  • 11. EBNA-2 of herpesvirus papio diverges significantly from the type A and type B EBNA-2 proteins of Epstein-Barr virus but retains an efficient transactivation domain with a conserved hydrophobic motif.
    Ling PD, Ryon JJ, Hayward SD.
    J Virol; 1993 Jun; 67(6):2990-3003. PubMed ID: 8388484
    [Abstract] [Full Text] [Related]

  • 12. Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression.
    Tsang SF, Wang F, Izumi KM, Kieff E.
    J Virol; 1991 Dec; 65(12):6765-71. PubMed ID: 1658373
    [Abstract] [Full Text] [Related]

  • 13. The Epstein-Barr virus EBNA-LP protein preferentially coactivates EBNA2-mediated stimulation of latent membrane proteins expressed from the viral divergent promoter.
    Peng R, Moses SC, Tan J, Kremmer E, Ling PD.
    J Virol; 2005 Apr; 79(7):4492-505. PubMed ID: 15767449
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus nuclear protein 2 transactivation of the latent membrane protein 1 promoter is mediated by J kappa and PU.1.
    Johannsen E, Koh E, Mosialos G, Tong X, Kieff E, Grossman SR.
    J Virol; 1995 Jan; 69(1):253-62. PubMed ID: 7983717
    [Abstract] [Full Text] [Related]

  • 15. Conserved regions in the Epstein-Barr virus leader protein define distinct domains required for nuclear localization and transcriptional cooperation with EBNA2.
    Peng R, Tan J, Ling PD.
    J Virol; 2000 Nov; 74(21):9953-63. PubMed ID: 11024123
    [Abstract] [Full Text] [Related]

  • 16. Epstein-Barr virus nuclear antigen 3C is a transcriptional regulator.
    Marshall D, Sample C.
    J Virol; 1995 Jun; 69(6):3624-30. PubMed ID: 7745710
    [Abstract] [Full Text] [Related]

  • 17. The EBNA-2 arginine-glycine domain is critical but not essential for B-lymphocyte growth transformation; the rest of region 3 lacks essential interactive domains.
    Tong X, Yalamanchili R, Harada S, Kieff E.
    J Virol; 1994 Oct; 68(10):6188-97. PubMed ID: 8083959
    [Abstract] [Full Text] [Related]

  • 18. Genetic analysis of the Epstein-Barr virus-coded leader protein EBNA-LP as a co-activator of EBNA2 function.
    McCann EM, Kelly GL, Rickinson AB, Bell AI.
    J Gen Virol; 2001 Dec; 82(Pt 12):3067-3079. PubMed ID: 11714985
    [Abstract] [Full Text] [Related]

  • 19. Multiple functions within the Epstein-Barr virus EBNA-3A protein.
    Cludts I, Farrell PJ.
    J Virol; 1998 Mar; 72(3):1862-9. PubMed ID: 9499037
    [Abstract] [Full Text] [Related]

  • 20. Identification of major phosphorylation sites of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP): ability of EBNA-LP to induce latent membrane protein 1 cooperatively with EBNA-2 is regulated by phosphorylation.
    Yokoyama A, Tanaka M, Matsuda G, Kato K, Kanamori M, Kawasaki H, Hirano H, Kitabayashi I, Ohki M, Hirai K, Kawaguchi Y.
    J Virol; 2001 Jun; 75(11):5119-28. PubMed ID: 11333893
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.